Full-Time
Clinical Scheduler
Confirmed live in the last 24 hours
Celerion
1,001-5,000 employees
Clinical research organization for drug development
Entry
Lincoln, NE, USA
Position requires onsite presence in Lincoln, NE.
- Associate's degree or equivalent experience required
- Data entry skills
- Internal clinical experience preferred
- Coordinate personnel schedules to meet study conduct needs
- Schedule proper personnel for studies
- Generate computerized conduct staff schedules
- Review existing schedules to ensure proper coverage and accuracy
- Schedule class training
- Work closely with training coordinators at each site to schedule new associates for training on study conduct events
- Assist in identifying training needs for clinic
- Assess the need for additional staff using availability reports and study schedules
- Identify scheduling needs for each study in conjunction with Study Managers
- Attend mandatory meetings - training, weekly initiation, CRD, closing of the books, interim conduct and dry runs
- Provide input on conduct design (set up) and staffing needs/requirements
Celerion specializes in early phase drug development as a clinical research organization (CRO). The company provides a range of services to pharmaceutical and biotechnology companies, including clinical trial design, feasibility studies, project management, and regulatory affairs. Celerion uses advanced bioanalytical techniques, particularly High Resolution Mass Spectrometry (HR MS), for metabolite profiling and identification, which enhances their research capabilities. This focus on bioanalytical sciences and their extensive experience allows Celerion to assist clients in making informed decisions during the early stages of drug development. Unlike many competitors, Celerion emphasizes speed and quality in their research processes, aiming to help clients bring new treatments to market more quickly, ultimately benefiting patients around the world.
Company Stage
Acquired
Total Funding
N/A
Headquarters
Lincoln, Nebraska
Founded
2010
6 month growth
↑ 11%1 year growth
↑ 11%2 year growth
↑ 15%
Simplify's Take
What believers are saying
- Celerion's global capabilities support the growing trend of decentralized clinical trials.
- The rise of precision medicine aligns with Celerion's expertise in specialized bioanalytical services.
- Expansion into GLP/GCP compliant testing positions Celerion well in cell and gene therapy markets.
What critics are saying
- Emerging CROs in Asia offer cost-effective solutions, threatening Celerion's market share.
- H.I.G. Capital's acquisition may disrupt client relationships or alter service offerings.
- Regulatory hurdles could delay the rollout of new GLP/GCP compliant testing services.
What makes Celerion unique
- Celerion specializes in early-phase drug development with over 40 years of experience.
- The company excels in metabolite profiling using High Resolution Mass Spectrometry (HR MS).
- Celerion offers comprehensive services including trial design, bioanalytical sciences, and regulatory affairs.
Help us improve and share your feedback! Did you find this helpful?